Healthcare provider profile · identity verified

Mary Ibrahim, MD

Internal Medicine · JERSEY CITY, NJ · NPI 1801983127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metformin Hcl	Metformin Hcl	299	47
Amlodipine Besylate	Amlodipine Besylate	293	52
Gabapentin	Gabapentin	268	45
Atorvastatin Calcium	Atorvastatin Calcium	232	41
Acarbose	Acarbose	213	32
Diclofenac Sodium	Diclofenac Sodium	207	38
Rosuvastatin Calcium	Rosuvastatin Calcium	201	39
Albuterol Sulfate Hfa	Albuterol Sulfate	177	36
Omeprazole	Omeprazole	175	32
Losartan Potassium	Losartan Potassium	151	23
Glimepiride	Glimepiride	148	24
Montelukast Sodium	Montelukast Sodium	139	20
Clopidogrel	Clopidogrel Bisulfate	131	16
Ibuprofen	Ibuprofen	111	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	108	16
Levothyroxine Sodium	Levothyroxine Sodium	103	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	102	16
Tamsulosin Hcl	Tamsulosin Hcl	96	13
Furosemide	Furosemide	95	16
Spironolactone	Spironolactone	93	15
Januvia	Sitagliptin Phosphate	90	suppressed
Meloxicam	Meloxicam	87	28
Fluticasone Propionate	Fluticasone Propionate	85	22
Meclizine Hcl	Meclizine Hcl	82	20
Naproxen	Naproxen	80	25
Alcohol Prep Pads	Alcohol Antiseptic Pads	74	13
Fenofibrate	Fenofibrate	72	17
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	70	14
Alendronate Sodium	Alendronate Sodium	69	12
Bisoprolol Fumarate	Bisoprolol Fumarate	66	suppressed
Donepezil Hcl	Donepezil Hcl	62	13
Pantoprazole Sodium	Pantoprazole Sodium	62	13
Pravastatin Sodium	Pravastatin Sodium	62	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	13
Ventolin Hfa	Albuterol Sulfate	61	suppressed
Hydralazine Hcl	Hydralazine Hcl	58	suppressed
Ketoconazole	Ketoconazole	58	13
Hydrochlorothiazide	Hydrochlorothiazide	53	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	13
Metoprolol Succinate	Metoprolol Succinate	53	suppressed
Ranolazine Er	Ranolazine	52	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	50	18
Lisinopril	Lisinopril	49	suppressed
Mupirocin	Mupirocin	49	19
Torsemide	Torsemide	48	suppressed
Azithromycin	Azithromycin	45	29
Linzess	Linaclotide	45	suppressed
Glipizide	Glipizide	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	15
Mometasone Furoate	Mometasone Furoate	41	14
Ammonium Lactate	Ammonium Lactate	40	suppressed
Carvedilol	Carvedilol	39	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	39	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Famotidine	Famotidine	37	suppressed
Glipizide Er	Glipizide	37	suppressed
Ozempic	Semaglutide	36	suppressed
Procto-Med Hc	Hydrocortisone	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Sertraline Hcl	Sertraline Hcl	33	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Levofloxacin	Levofloxacin	31	27
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Eliquis	Apixaban	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Sucralfate	Sucralfate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Dexlansoprazole Dr	Dexlansoprazole	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Simvastatin	Simvastatin	25	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Creon	Lipase/Protease/Amylase	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Loperamide	Loperamide Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Tobramycin	Tobramycin	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Colchicine	Colchicine	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Finasteride	Finasteride	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Atenolol	Atenolol	16	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	15	suppressed
Baclofen	Baclofen	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Letrozole	Letrozole	15	suppressed
Mupirocin	Mupirocin Calcium	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error